BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/25/2024 10:19:39 AM | Browse: 41 | Download: 0
Publication Name World Journal of Transplantation
Manuscript ID 91146
Country United States
Category Medicine, General & Internal
Manuscript Type Editorial
Article Title Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation
Manuscript Source Invited Manuscript
All Author List Arthur Dilibe, Lakshmi Subramanian, Tracy-Ann Poyser, Osejie Oriaifo, Ryan Brady, Sashwath Srikanth, Olanrewaju Adabale, Olayiwola Akeem Bolaji and Hassam Ali
Funding Agency and Grant Number
Corresponding Author Hassam Ali, MD, Doctor, Division of Gastroenterology and Hepatology, East Carolina University/Brody School of Medicine, 2100 Statonsburg Road, Greenville, Greenville, NC 27858, United States. hassamali155@gmail.com
Key Words Posterior reversible encephalopathy syndrome; Liver transplantation; Tacrolimus; Immunocompromised patients; Neurological complications; Solid organ transplant
Core Tip Tacrolimus, a crucial immunosuppressant in liver transplantation, is associated with the rare but serious complication of posterior reversible encephalopathy syndrome (PRES). Although the incidence is relatively low (0.5%-5%) in solid organ transplant recipients, the presentation of PRES can vary significantly, including seizures and visual disturbances. This condition, primarily affecting the parietal and occipital lobes, underscores the need for diligent monitoring and early intervention in liver transplant patients undergoing Tacrolimus therapy. The case presented highlights the complexities in diagnosing and managing Tacrolimus-related PRES, emphasizing the critical balance between adequate immunosuppression and the risk of severe neurological adverse effects.
Citation Dilibe A, Subramanian L, Poyser TA, Oriaifo O, Brady R, Srikanth S, Adabale O, Bolaji OA, Ali H. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World J Transplant 2024; In press
Received
2023-12-23 00:22
Peer-Review Started
2023-12-23 00:22
To Make the First Decision
Return for Revision
2024-03-31 00:09
Revised
2024-04-13 22:19
Second Decision
2024-04-25 02:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-04-25 10:19
Articles in Press
2024-04-25 10:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com